Regresión de la arterosclerosis: ¿Mito o Realidad?


Roberto Lecaro
2012-10-04

More articles by this author

Intervenciones coronarias: optimizando la farmacología

Conrad Simpfendorfer.2012-10-04

¿Qué tanto nos adherimos a las guidelines AHA?

Dario Echeverri 2012-10-04

Selección de DES para Diabéticos: Análisis de evidencias

Mariano Albertal 2012-10-04

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...